Cytosorbents Ratios (2010-2026) | CTSO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	77.46%	74.77%	71.04%	73.79%	58.21%	44.60%	61.31%	57.73%	63.89%	63.64%	61.27%	76.46%	73.55%	61.02%	68.35%	71.12%	70.85%	70.28%	73.68%	69.16%
EBT Margin (Quarter)	-38.90%	-65.64%	-93.14%	-103.16%	-128.06%	-150.42%	-19.79%	-77.49%	-70.07%	-104.28%	-80.16%	-67.73%	-48.58%	-32.14%	26.94%	-16.94%	-262.17%	-37.65%	-59.53%	-124.55%
EBIT Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.55%	-37.59%	-30.17%	-47.49%	-34.34%
EBITDA Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.55%	-37.59%	-30.17%	-47.49%	-34.34%
Operating Margin (Quarter)	-40.96%	-55.39%	-88.68%	-89.64%	-98.37%	-111.17%	-67.69%	-83.51%	-69.62%	-83.42%	-108.54%	-51.80%	-40.38%	-56.08%	-37.10%	-44.55%	-37.59%	-30.17%	-47.49%	-34.34%
Net Margin (Quarter)	-38.90%	-65.64%	-86.32%	-103.16%	-128.06%	-150.42%	-8.16%	-77.53%	-65.31%	-104.34%	-67.31%	-70.73%	-48.56%	-32.14%	-82.69%	-16.95%	20.25%	-33.42%	-59.53%	-57.86%
FCF Margin (Quarter)	-23.49%	-29.88%	-84.70%	-101.59%	-88.98%	-152.61%	1.85%	-32.89%	-73.60%	-59.09%	-80.13%	-54.23%	-54.42%	-30.36%	-23.32%	-39.74%	-16.08%	-27.35%	-53.42%	-13.23%
Efficiency
Inventory Average (Quarter)	3.40M	4.11M	4.65M	5.11M	5.21M	4.26M	3.50M	2.59M	1.89M	2.51M	3.18M	3.56M	4.03M	3.78M	2.99M	2.88M	3.36M	3.86M	4.65M	4.89M
Assets Average (Quarter)	92.84M	96.63M	92.29M	86.40M	77.24M	66.74M	62.75M	60.35M	54.95M	50.01M	50.27M	50.01M	50.25M	50.62M	47.59M	49.08M	49.39M	46.87M	44.97M	42.37M
Invested Capital (Quarter)										0.83M	2.50M	2.50M						15.00M		6.65M
Asset Utilization Ratio (Quarter)	0.49	0.46	0.47	0.48	0.49	0.54	0.55	0.59	0.66	0.74	0.72	0.72	0.70	0.69	0.75	0.72	0.73	0.79	0.82	0.88
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-0.73	-0.60	-4.86	-10.93	-12.20	-13.68	-2.17	-12.47	-1.10	-11.61	-15.63	-2.54	-35.70	-2.55	-7.56	-7.14	-0.17	-11.93	-2.33	-0.38
Debt Ratio (Quarter)							0.08	0.09	0.10	0.11	0.10	0.09	0.26	0.29	0.30	0.28	0.30	0.32	0.38	0.42
Times Interest Earned (Quarter)	-0.73	-0.60	-4.86	-10.93	-12.20	-13.68	-2.17	-12.47	-1.10	-11.61	-15.63	-2.54	-35.70	-2.55	-7.56	-7.14	-0.17	-11.93	-2.33	-0.38
Valuation
Enterprise Value (Quarter)	-65.61M	-61.04M	-52.14M	-43.02M	-30.16M	-22.55M	-22.14M	-19.05M	-13.15M	-8.36M	-14.13M	-8.61M	-8.46M	-6.50M	-14.76M	-13.11M	-10.20M	-7.54M	-6.25M	-4.80M
Return Ratios
Return on Sales (Quarter)	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	-0.03%	0.00%	0.00%	-0.01%
Return on Capital Employed (Quarter)	-15.08%	-18.49%	-28.94%	-38.60%	-46.66%	-61.34%	-59.43%	-62.13%	-66.32%	-73.45%	-86.14%	-75.02%	-61.53%	-53.07%	-43.56%	-39.86%	-39.77%	-37.43%	-41.84%	-53.34%
Return on Invested Capital (Quarter)	-0.01%										-0.14%	-0.06%		-0.04%	-0.03%				-0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%

Research Tools

Developers

Cytosorbents Ratios (2010-2026) | CTSO

Research Tools

Developers

Cytosorbents Ratios (2010-2026) | CTSO

Create an account

Sign In

Reset Password